Special Edition: What's Next—Understanding Chronic Kidney Disease in People with Diabetes—Epidemiology, Pathophysiology, and Detection - March 2026

Special Edition: What's Next—Understanding Chronic Kidney Disease in People with Diabetes—Epidemiology, Pathophysiology, and Detection - March 2026

In this special edition on CKD our host, Dr. Neil Skolnik will discuss epidemiology, pathophysiology and screening for CKD in People with Diabetes. This special episode is supported by an independent educational grant from Bayer.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Holly Kramer, M.D., Professor of Public Health Sciences and Medicine in the Division of Nephrology and Hypertension at Loyola University Chicago, past-president of the National Kidney Foundation, Editor-in-Chief of the National Kidney Foundation's journal, Advances in Kidney Disease and Health (AKDH).

Selected references:

Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 . The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1) :S246–S260

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(100)

Special Edition: What's Next—Cardiovascular Risk in CKD—The Overlooked Burden

Special Edition: What's Next—Cardiovascular Risk in CKD—The Overlooked Burden

We have only recently become aware of the close relationship between the heart and the kidneys. In today's discussion, Dr. Neil Skolnik speaks with Dr. Josephine Harrington to gain insight into these ...

12 Maj 30min

Special Edition: What's Next—Once-Weekly Insulin

Special Edition: What's Next—Once-Weekly Insulin

In the early 2000s, long-acting, once-daily insulin was approved, completely changing the experience of using insulin for people with diabetes. But science doesn't stand still. Now the FDA has approve...

5 Maj 20min

Associations between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy, Tirzepetide vs. Dulaglutide or Semaglutide on major cardiovascular events in T2D, and more!

Associations between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy, Tirzepetide vs. Dulaglutide or Semaglutide on major cardiovascular events in T2D, and more!

Welcome to the latest episode (May 2026) of Diabetes Core Update, where every month Neil Skolnik, MD and John Russell, MD review the most important articles on diabetes, obesity, and cardiometabolic d...

1 Maj 36min

Special Edition: What's Next—Emerging Technologies for People with Diabetes

Special Edition: What's Next—Emerging Technologies for People with Diabetes

In this special edition on Emerging Technologies for People with Diabetes our host, Dr. Neil Skolnik will discuss recent and future advances in technologies for people with diabetes. This special epis...

15 Apr 35min

The Points of CARE - James Gavin & Naunihal Virdi on CGM Use in Noninsulin-Treated Patients, Ivy Shi & Dhruv Kazi on GLP-1 RA Eligibility in Reproductive-Age US Women, and Eva Tseng on START Diabetes Prevention

The Points of CARE - James Gavin & Naunihal Virdi on CGM Use in Noninsulin-Treated Patients, Ivy Shi & Dhruv Kazi on GLP-1 RA Eligibility in Reproductive-Age US Women, and Eva Tseng on START Diabetes Prevention

With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast: The Points of CARE, the official podcast of Diabetes, Obesity, and CardioMetabolic CARE...

8 Apr 30min

Special Edition - Continuous Ketone Monitoring April 2026

Special Edition - Continuous Ketone Monitoring April 2026

In this special edition on Continuous Ketone Monitoring our host, Dr. Neil Skolnik will discuss this new technology – its promise and its application. This special episode is supported by an independe...

7 Apr 26min

Diabetes Core Update – April 2026

Diabetes Core Update – April 2026

This issue will review: 1.     Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide 2.     Estimated Optimal Individualized Diabetes Risk Prediction From Preventive Interventions in the...

1 Apr 26min

Special Edition - Obesity as a Chronic Disease - Treatment Approach March 2026

Special Edition - Obesity as a Chronic Disease - Treatment Approach March 2026

In this special edition on Obesity as a Chronic Disease our host, Dr. Neil Skolnik will discuss the approach to treatment of obesity. This special episode is supported by an independent educational gr...

24 Mars 40min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
inga-beiga-morsor
rss-jossan-nina
rss-vuxna-pa-latsas
johannes-hansen-podcast
not-fanny-anymore
rss-viktmedicinpodden
sexnoveller-deluxe
angestpodden
sova-med-dan-horning
rss-real-talk-with-jesper-stahl
rss-basta-livet
rss-relationsrevolutionen
brottarbroder
sa-in-i-sjalen
rss-sjalsligt-avkladd
rss-hos-psykologen
tyngre-traningssnack
tyngre-radio